drugset / Trial / NCT00265265

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

NCT00265265

Phase 1 Completed 16 enrolled National Institute on Drug Abuse (NIDA)
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.

Timeline

Start
2005-08
Primary completion
2006-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 100 mg Oral

Indications